A Single Peripheral CD8+ T Cell Can Give Rise to Progeny Expressing Type 1 And/or Type 2 Cytokine Genes and Can Retain Its Multipotentiality Through Many Cell Divisions
Overview
Affiliations
The lineage relationships between murine CD8(+) T cells with different cytokine profiles were investigated by paired-daughter analysis in the presence and absence of the type 2 cytokine-inducing stimulus, interleukin 4 (IL-4). Single CD8(+) CD44(low) lymph node T cells were activated to divide at high frequency with IL-2 and immobilized antibodies to CD3, CD8, and LFA-1. When these parent cells were subcloned by transferring their daughter or granddaughter cells into secondary cultures with or without IL-4, the subclones expressed diverse combinations of the mRNAs for the type 1 cytokines, interferon gamma (IFN-gamma), and IL-2, and the type 2 cytokines, IL-4, IL-5, IL-6, and IL-10. Frequencies of subclones that expressed IL-4, IL-6, and, to a lesser extent, IL-2, IL-5, and IL-10 were higher among those grown with IL-4, but a significant proportion of those grown without exogenous IL-4 also expressed one or more type 2 cytokines. Subclones within 89% of families displayed different cytokine profiles, indicating that their parent cells were multipotential for this function. Because 98% of parent cells yielded subclones that produced type 1 cytokines and 77% yielded type 2 cytokine producers, we conclude that type 1 and type 2 cytokine-producing CD8(+) T cells can be derived from a common precursor. Similar analyses performed by subcloning after >/=7 or >/=13 cell divisions without IL-4 showed that many CD8(+) T cells retained the potential to shift toward a type 2 cytokine profile in response to IL-4, even after prolonged expansion under conditions that favored type 1 cytokine expression. CD8(+) T cells that express type 1 and/or type 2 cytokines therefore are derived from the same peripheral T cell lineage whose multipotentiality can persist through many cell divisions.
Development of Adaptive Immunity and Its Role in Lung Remodeling.
Esnault S, Jarjour N Adv Exp Med Biol. 2023; 1426:287-351.
PMID: 37464127 DOI: 10.1007/978-3-031-32259-4_14.
Crofts K, Holbrook B, Soto-Pantoja D, Ornelles D, Alexander-Miller M Front Immunol. 2020; 11:540.
PMID: 32300344 PMC: 7145404. DOI: 10.3389/fimmu.2020.00540.
Fox A, Harland K, Kedzierska K, Kelso A Front Immunol. 2018; 9:1141.
PMID: 29892290 PMC: 5985406. DOI: 10.3389/fimmu.2018.01141.
Yang C, Khanniche A, DiSpirito J, Ji P, Wang S, Wang Y Sci Rep. 2016; 6:27005.
PMID: 27243788 PMC: 4886650. DOI: 10.1038/srep27005.
Harland K, Day E, Apte S, Russ B, Doherty P, Turner S Nat Commun. 2014; 5:3547.
PMID: 24675400 PMC: 3974221. DOI: 10.1038/ncomms4547.